Chemical apparatus and process disinfecting – deodorizing – preser – Analyzer – structured indicator – or manipulative laboratory... – Calorimeter
Reexamination Certificate
2005-10-25
2005-10-25
Gakh, Yelena G. (Department: 1743)
Chemical apparatus and process disinfecting, deodorizing, preser
Analyzer, structured indicator, or manipulative laboratory...
Calorimeter
C422S051000, C422S067000, C435S014000
Reexamination Certificate
active
06958129
ABSTRACT:
The present invention is directed to a single test system and method for determining the integrated glycemic condition of a subject by measuring the concentration of glucose and the level of protein-bound glucose in a subject's body fluid, such as whole blood. The glucose concentration is indicative of the subject's immediate glycemic condition, whereas the protein-bound glucose concentration is indicative of either intermediate or long-term glycemic condition. Optionally, other analytes indicative of glycemic condition, such as ketone bodies or fatty acid derivatives, can also be measured. The present invention also provides a method of diagnosing diabetes. The invention additionally provides a method for analyzing the concentration of fructosamine in less than or equal to five minutes without the use of a reaction accelerator.
REFERENCES:
patent: 3552929 (1971-01-01), Fields et al.
patent: 3802842 (1974-04-01), Lange et al.
patent: 3809605 (1974-05-01), Schmitt et al.
patent: 3897214 (1975-07-01), Lange et al.
patent: 3973849 (1976-08-01), Jackson et al.
patent: 4042335 (1977-08-01), Clement
patent: 4050898 (1977-09-01), Goffe, et al.
patent: 4223995 (1980-09-01), Fletcher
patent: 4269605 (1981-05-01), Dean et al.
patent: 4397956 (1983-08-01), Maggio
patent: 4478744 (1984-10-01), Mezei et al.
patent: 4482251 (1984-11-01), Saylor
patent: 4545382 (1985-10-01), Higgins et al.
patent: 4642295 (1987-02-01), Baker
patent: 4645742 (1987-02-01), Baker
patent: 4681444 (1987-07-01), Ferber et al.
patent: 4729657 (1988-03-01), Cooper et al.
patent: 4744657 (1988-05-01), Aralis et al.
patent: 4806468 (1989-02-01), Wagner et al.
patent: 4852025 (1989-07-01), Herpichbohm
patent: 4866644 (1989-09-01), Shenk et al.
patent: 4935346 (1990-06-01), Phillips et al.
patent: 4956301 (1990-09-01), Ismail et al.
patent: 4999582 (1991-03-01), Parks et al.
patent: 5002893 (1991-03-01), Rosenthal
patent: 5049487 (1991-09-01), Phillips et al.
patent: 5059394 (1991-10-01), Phillips et al.
patent: 5075077 (1991-12-01), Durley, III et al.
patent: 5110745 (1992-05-01), Kricka et al.
patent: 5169787 (1992-12-01), Knappe et al.
patent: 5179005 (1993-01-01), Phillips et al.
patent: 5183739 (1993-02-01), Cohen
patent: 5206144 (1993-04-01), Zeuthen et al.
patent: 5215716 (1993-06-01), Arai
patent: 5223219 (1993-06-01), Subramanian et al.
patent: 5243516 (1993-09-01), White
patent: 5258163 (1993-11-01), Krause et al.
patent: 5271895 (1993-12-01), McCroskey et al.
patent: 5281395 (1994-01-01), Markart et al.
patent: 5284777 (1994-02-01), Rosenthal et al.
patent: 5304468 (1994-04-01), Phillips et al.
patent: 5366868 (1994-11-01), Sakamoto
patent: 5384239 (1995-01-01), Saunders
patent: 5470752 (1995-11-01), Burd et al.
patent: 5571723 (1996-11-01), Evans et al.
patent: 0388782 (1990-09-01), None
patent: 0473189 (1992-03-01), None
patent: WO 96/00897 (1996-01-01), None
Armburster, “Diabetes mellitus, protein glycation, and laboratory assays for monitoring long-term glycemic control.”Clinical Laboratory Science, 3(3):184-188 (1990).
Armbuster, “Fructosamine: Structure, Analysis, and Clinical Usefulness.”Clinical Chemistry, 33(12):2153-2163 (1987).
Baker et al., “Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.”British Med. J., 287:863-867 (1983).
Benjamin and Sacks, “Glycated protein update: implications of recent studies, including the diabetes control and complications trial.”Clin. Chem., 40(5):683-687 (1994).
Caines et al., “Colorimetric determination of non-enzymatically glycated albumin.”Clinical Biochemistry, 19:26-30 (Feb. 1986).
Candiloros, “Decreased Erythrocyte Membrane Fluidity in Poorly Controlled IDDM.”Diabetes Care, 18(4) 549-551 (1995).
Cefalu et al., “Serum fructosamine as a screening test for diabetes in the elderly: a pilot study.”JAGS, 41:1090-1094 (1993).
Dix et al., “Glycohemoglobin and glucose tolerance tests compared as indicators of borderline diabetes.”Clin. Chem., 25(6):877-879 (1979).
Dods and Bolmey, “Glycosylated hemoglobin assay and oral glucose tolerance test compared for detection of diabetes mellitus,”Clin. Chem.25(5):764-768 (1979).
Goldstein et al., “Is glycohemoglobin testing useful in diabetes mellitus? Lessons from the diabetes control and complications trial.”Clin. Chem.,40(8):1637-1640 (1994).
Goldstein and Little, “The impact of the diabetes control and complications trial on the clinical laboratory.”Viewpoints, 4 (1993).
Guillausseau et al., “Comparison of HbA1and fructosamine in diagnosis of glucose-tolerance abnormalities.”Diabetes Care13(8):898-890 (1990).
Johnson et al., “Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.”Clinica Chimica Acta, 127:87-95 (1982).
Kahn, “Tight blood glucose control shown beneficial for diabetes.”Clin. Chem. News, 19(9) (1993).
Larsen et al., “Effect of long-term monitoring of glycosylated hemoglobin levels in-insulin-dependent diabetes mellitus.”New England J. of Med., 323(15):1021-1025 (1990).
Pamphlet Insert to the Abbott Vision System, (1993).
Pamphlet Insert to the Lifescan, One Touch II Blood Glucose Meter, (1990).
Rosen, “Protein-Bound glucose as a screening test for diabetes.”Hospital Practice, 27:59-61 (1992).
Rowe DJF, “The Measurement and Clinical Significance of Glycated Proteins.”Practical Diabetes, 6(6) 256-260 (1989).
Shima et al., “The relative value of glycated albumin, hemoglobin A1cand fructosamine when screening for diabetes mellitus.”Diabetes Research and Clin. Practice, 7:243-250 (1989).
Searcy and Bolland, “Fructosamine: The next step in diabetic management.”Amer. Clin. Lab. 12(8) 1993.
Thbsalemans et al., “The value of HbA1and fructosamine in predicting impaired glucose tolerance—an alternative to OGTT to detect diabetes mellitus or gestational diabetes.”Ann. Clin. Biochem., 24:447-452 (1987).
English Abstract of Japanese Patent JP63182567 published Jul. 27, 1988, Applicant Tsolab, Inc.
English Abstract of Japanese Patent JP5209836 published Aug. 20, 1993, Applicant TeruMo Corp.
English Abstract of Japanese Patent JP4110662 published Apr. 13, 1992, Applicant Kiyouto Dalichi Kagaku:KK.
English Abstract of Japanese Patent JP52131786 published Nov. 4, 1997, Applicant Eastman Kodak Co.
Letter from Shusaku Yamamoto dated Sep. 7, 2004 forwarding Japanese Office Action and Search Results.
Burd John F.
Galen Robert S.
Hoblitzell Talei
Neyer Gebhard
Gakh Yelena G.
LifeScan, Inc.
LandOfFree
Combined assay for current glucose level and intermediate or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined assay for current glucose level and intermediate or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined assay for current glucose level and intermediate or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3475646